DBS Group Research’s Woon Bing Yong and Ling Lee Keng have downgraded their rating for Medtecs International from ‘buy’ to ‘hold’, as well as lowering their target price to 92 cents from $1.25. 

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply